Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc. (MLYS) and Encourages Shareholders to Learn More About the InvestigationAccesswire • 09/24/24
Mineralys Therapeutics, Inc. May Have Defrauded The Public And Shareholders Are Urged To Help The Schall Law Firm InvestigateAccesswire • 09/23/24
Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the InvestigationAccesswire • 09/23/24
MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!GlobeNewsWire • 09/22/24
The Schall Law Firm Seeks Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Violating Securities LawsAccesswire • 09/22/24
Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc. (MLYS) Shareholders to Inquire about Securities InvestigationAccesswire • 09/22/24
Mineralys Therapeutics, Inc. Is Being Investigated By The Schall Law Firm For Securities Fraud And Stakeholders Are Urged To ContributeAccesswire • 09/21/24
The Schall Law Firm Has Launched An Inquiry Into Mineralys Therapeutics Inc For Violating Securities Laws And Affected Investors Should Reach OutAccesswire • 09/20/24
Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Shareholders to ConnectAccesswire • 09/20/24
Mineralys Therapeutics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders To Take PartAccesswire • 09/19/24
Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc. (MLYS) Stockholders to Inquire about Securities InvestigationAccesswire • 09/19/24
Investors Are Invited By The Schall Law Firm To Join An Inquiry Into Mineralys Therapeutics Inc For Securities Law ViolationsAccesswire • 09/18/24
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc. (MLYS) and Encourages Investors to Learn More About the InvestigationAccesswire • 09/18/24
The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Stockholders Should Reach OutAccesswire • 09/17/24
Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationAccesswire • 09/17/24
Mineralys Therapeutics Inc May Have Engaged In Securities Law Violations And The Schall Law Firm Urges Investors With Losses To Partake In An InquiryAccesswire • 09/16/24
Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Investors to ConnectAccesswire • 09/16/24
The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Shareholders Should Reach OutAccesswire • 09/15/24
Mineralys Therapeutics Inc May Have Committed Securities Law Violations And The Schall Law Firm Invites Investor Participation In An InquiryAccesswire • 09/14/24
The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Stockholders Should Reach OutAccesswire • 09/13/24
Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire • 09/13/24
Mineralys Therapeutics Inc May Have Violated Securities Laws And The Schall Law Firm Invites Investors To Join An InquiryAccesswire • 09/12/24
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc.(MLYS) and Encourages Stockholders to Learn More About the InvestigationAccesswire • 09/12/24
The Schall Law Firm Is Looking Into Whether Mineralys Therapeutics, Inc. Committed Securities Fraud And Affected Shareholders Can Reach OutAccesswire • 09/11/24
